Branwen Morgan PhD

Branwen Morgan PhD MAICD

Professor Branwen Morgan is a STEMM specialist with broad sector knowledge, a wide-ranging skill set, and an extensive professional network. She also has a PhD (Neuroscience) and has worked as a journalist and corporate communications professional in the UK and Australia. Branwen has covered breaking news and written investigational pieces relating to research impact assessment, measuring innovation, trends in drug discovery and mechanisms of disease.

Branwen Sarah Morgan +61 499 976421 bsmcommunications’at’me.com

Experience

Branwen has held numerous senior roles that bridge academic organisations, government, publicly listed companies, and NGOs. In each position, she has drawn on her extensive strategic communication and engagement skills to deliver programme and organisational outcomes. She is currently a research director and lead of the Minimising Antimicrobial Resistance Mission at Australia’s national science agency CSIRO.

Prior to CSIRO, Branwen was the general manager for the Australian Centre for Genomic Epidemiological Microbiology (AusGEM), a research partnership that draws on scientific expertise within the University of Technology Sydney and the NSW Department of Primary Industries.

Her STEMM network, biomedical knowledge and digital understanding led to her advising a startup business that was part of PWC’s 21st Century Minds (21CM) programme and being employed as a research translation and innovation consultant to global science publishing house Springer Nature, for whom she has been writing since 2009. Branwen has chaired a number of Australia British Chamber of Commerce (ABCC) and Springer Nature panels and she was a keynote speaker at ACCORD’s 2016 national conference where she spoke on risk and innovation.

Branwen’s articles have appeared in: Nature, Nature Index and Nature Medicine, ABC News in Science, Cosmos, Sydney Morning Herald, BBC News online, Australian Doctor, Australian Medicine, Trends in Neurosciences, New Scientist, Today’s Life Sciences, Australasian Science, Lab News, BioMedNet, The Scientist, and Newton.

Latest articles

Elastagen: High-tech wound and tissue healing

Whole genome sequencing is medicine’s Snowy Scheme

How should governments measure innovation?

Defining national research priorities

In research, time is as important as money

Is backing bright people a bright idea?

Game changers – The Google of Genomes and Antibodies as Therapy

August 15, 2017

Published online 09 August 2017 Basic Local Alignment Search Tool published in the Journal of Molecular Biology in 1990. Inferring the function of a protein 40 years ago required finding a related protein with a known function. To determine the similarity between two proteins meant comparing their amino acid sequences using a time-consuming algorithm. … More Game changers – The Google of Genomes and Antibodies as Therapy

Elastagen: High-tech wound and tissue healing

August 15, 2017

17 May 2017 With initial proof-of-concept financing secured in 2005, Elastagen should be considered a teenager in start-up years. But biotechnology that relies on wet materials rather than software or devices has a much longer road to commercialization. The idea behind the company’s offering is even older. In 1995, a research team at the … More Elastagen: High-tech wound and tissue healing

Whole genome sequencing is medicine’s Snowy Scheme (The Australian)

April 13, 2017

John Mattick (1), Branwen Morgan (2) (1) Executive Director, Garvan Institute of Medical Research, Sydney (2) Visiting Fellow, Garvan Institute of Medical Research, Sydney We are on the brink of a revolution in healthcare. Genomics soon will help us not just cure but also predict and even prevent diseases such as diabetes, dementia, cancer and … More Whole genome sequencing is medicine’s Snowy Scheme (The Australian)

What has animal research done for the brain?

A 27 minute documentary-style film, produced for the Coalition for Medical Progress (2004)